September 2026
The vascular patches market is forecast to increase from USD 547.00 million in 2025 to USD 1,051.15 million by 2035, at a CAGR of 6.75%.
September 2026
The global vascular access devices market size is projected to attain around USD 3.36 billion by 2034 from USD 2.24 billion by 2026, with a solid CAGR of 5.22%.
September 2026
The vascular closure devices market size was valued at USD 1.77 billion in 2026 and is expected to surpass around USD 2.76 billion by 2034, with a CAGR of 5.73%.
June 2026
The global vascular grafts market size is evaluated at USD 6.29 billion in 2025 and is projected to hit around USD 10.33 billion by 2035 with a notable CAGR of 5.09%.
September 2026
The global cardiovascular ultrasound market size reached USD 3.20 billion in 2026 and is projected to surpass around USD 5.61 billion by 2035 with a CAGR of 6.42%.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The global cardiovascular devices market size is expected to increase from USD 80.61 billion in 2026 to hit around USD 158.41 billion by 2035, with a CAGR of 7.81%.
September 2026
The cardiovascular digital solutions market size is expected to hit around USD 212.53 billion by 2035 from USD 135.10 billion in 2026 with a CAGR of 5.17%.
September 2026
The neurovascular catheters market size accounted for USD 6.88 billion in 2026 and it is expected to hit around USD 13.20 billion by 2035 with a CAGR of 7.56%.
September 2026
The intravascular lithotripsy market reached USD 1.24 billion in 2026, with prominent companies such as Shockwave Medical, Boston Scientific, Medtronic leading the intravascular lithotripsy market.
September 2026
The neurovascular devices market size is calculated at USD 3.54 billion in 2026 and is projected to hit around USD 7.12 billion by 2035 with a CAGR of 8.20%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global interventional cardiology and peripheral vascular device market size is expected to increase from USD 30.36 billion in 2026 to hit around USD 63.80 billion by 2035, growing at a CAGR of 8.60%.
September 2026
The global intravascular imaging market size reached USD 457.17 billion in 2026 and is projected to surpass around USD 697.37 million by 2034, with a notable CAGR of 5.42%.
September 2026
The U.S. cardiovascular drugs market was valued at USD 29.25 billion in 2026, with leading companies including Bristol-Myers Squibb, Bayer AG, Pfizer Inc.
July 2026
The next gen cardiovascular treatments market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global neurovascular thrombectomy devices market size is anticipated at USD 825.92 million in 2025 and is predicted to hit around USD 1,585.54 million by 2035, growing at a CAGR of 6.74%.
April 2026
The global neurovascular embolization devices market size is estimated to hit around USD 4.58 billion by 2035 increasing from USD 1.5 billion in 2025, with a CAGR of 11.80%.
February 2026
The global cardiovascular genetic testing market size was evaluated at USD 11.34 billion in 2025 and is predicted to hit around USD 33.38 billion by 2035, growing at a CAGR of 11.4%.
July 2025
The global stromal vascular fraction market size is estimated to hit around USD 5.02 billion by 2034 increasing from USD 1.95 billion in 2026, with a CAGR of 12.54%.
June 2025
The global cardiovascular health supplements market size reached USD 12.04 billion in 2024 and is projected to surpass around USD 25.83 billion by 2034 with a CAGR of 7.93%.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com